Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Bristol-Myers Squibb Reports Third Quarter Financial Results
October 27, 2016 6:59 AM EDTIncreases Third Quarter Revenues 21% to $4.9 Billion Posts Third Quarter GAAP EPS of $0.72 and Non-GAAP EPS of $0.77 Achieves Key Regulatory Milestones for Opdivo Positive Advisory Opinion for the Treatment of Classical Hodgkin Lymphoma in Europe Application for Advanced Form of Bladder Cancer Accepted for Priority Review in U.S., Validated in Europe Announces Approval of $3 Billion Share Repurchase Authorization Announces Operating Model Evolution for Sustained Growth... More
